Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #86866 on Biotech Values
hptaxis
12/01/09 4:45 PM
#86867 RE: wallstarb #86866
Hemispherx is carefully reviewing the Complete Response letter and will seek an expedited meeting with the FDA to discuss its recommendations. Management is pleased to have received specific advice on the remaining issues and is looking forward to making a thorough but expedited response its top priority, and plans to take all appropriate steps to seek approval and commercialization of Ampligen(R).
tony111
12/01/09 4:47 PM
#86868 RE: wallstarb #86866
AlpineBV_Miller
12/01/09 6:06 PM
#86871 RE: wallstarb #86866
First I have ever seen where the FDA actually writes "ROTFLMAO" in the letter!